Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Cytel and Schwarz terminate research collaboration

May 6, 1997

Results from analysis of 10 years of amiodarone therapy presented

May 6, 1997

CytRx initiates new phase II trial of purified RheothRx

May 5, 1997

Lp-PLA2 inhibitors from SmithKline Beecham

May 5, 1997

Zeneca and the University of Oxford enter collaboration for genetic research into heart disease

May 2, 1997

Calcium antagonist shown to cause left ventricular hypertrophy regression

April 30, 1997

Roche discloses human renin inhibitors

April 30, 1997

Kissei prepares smooth muscle cell proliferation inhibitors

April 30, 1997

Novel cardiac antiischemic agents disclosed by Kanebo

April 30, 1997

Endothelin antagonists reported by Kowa

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...